On November 9, 2021, NCD Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held the first advisory board meeting of the Platform Project for Patient and Public Involvement.

At the meeting, we deepened the discussion on issues that may be encountered when promoting Patient and Public Involvement (PPI) in policy making forums based on the results of preliminary hearings conducted with patients, other healthcare beneficiaries, and experts.

To prevent the potential spread of Coronavirus Disease 2019 (COVID-19), this meeting was held remotely over an online conferencing system.

For more information, please refer to the PDF.

■ Overview
Date and time: Tuesday, November 9, 2021; 18:00 – 19:30
Secretariat: Health and Global Policy Institute

■ Program
Opening remarks and project explanation
 Yuko Imamura (Manager, HGPI)

Explanation of results of preliminary hearings
 Shotaro Tsukamoto (Associate, HGPI)

Discussion: Issues Facing Patient and Public Involvement in Policy Making Forums
Moderator:
 Tomohito Shibata (Manager, HGPI)

Closing remarks
 Ryoji Noritake (CEO, Board Member, HGPI)

Advisory board members (in no particular order; titles omitted)
Kyoko Ama (Representative, Children and Healthcare Project; Fellow, HGPI)
Shinsuke Amano (Chair, The Japan Federation of Cancer Patient Groups; CEO, Group Nexus Japan)
Yoshiko Kobata (Director, CSR Promotion Office, General Affairs Bureau, Fuji Television Network, Inc.)
Naomi Sakurai (President, Cancer Solutions Co., Ltd)
Yasuhiro Sensho (CEO, SENSHO-GUMI, Co., Ltd.; Former Director-General, MHLW)
Teppei Maeda (Lawyer, Maeda & Unosawa Law Offices; Representative, Medical Basic Act Community)
Kaori Muto (Professor, Department of Public Policy Studies, Institute of Medical Science, University of Tokyo)
Ikuko Yamaguchi (Chief Director, Consumer Organization for Medicine and Law (COML))

Special advisor
Yuji Inokuchi (Vice-President, Japan Medical Association